As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Boston Scientific: Hudson Bay Capital Management LP, Nomura Holdings Inc., LMR Partners LLP, Hudson Bay Capital Management LP, Group One Trading LLC, Cubist Systematic Strategies LLC, BNP Paribas Financial Markets, Balyasny Asset Management L.P., Bank of America Corp DE, Jane Street Group LLC, Caption Management LLC, Volterra Technologies LP, Squarepoint Ops LLC, Qube Research & Technologies Ltd, Maven Securities LTD, Capula Management Ltd, Walleye Capital LLC, Walleye Trading LLC, Lido Advisors LLC, Delta Accumulation LLC, Capital Fund Management S.A., Hsbc Holdings PLC, Eisler Capital Management Ltd., JPMorgan Chase & Co., Citigroup Inc., Credit Industriel ET Commercial, Huntington National Bank, Allianz Asset Management GmbH, Twin Tree Management LP, Credit Industriel ET Commercial, Concurrent Investment Advisors LLC, and Wealth Enhancement Advisory Services LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.